Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Capital Employed (2022 - 2025)

Autolus Therapeutics (AUTL) has disclosed Return on Capital Employed for 3 consecutive years, with 0.32% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Return on Capital Employed rose 20.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Dec 2024, up 20.0%, and an annual FY2024 reading of 0.47%, changed 0.0% over the prior year.
  • Return on Capital Employed was 0.32% for Q4 2024 at Autolus Therapeutics, down from 0.28% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.28% in Q3 2024 and bottomed at 0.52% in Q4 2023.
  • Average Return on Capital Employed over 3 years is 0.35%, with a median of 0.32% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -21bps in 2023, then grew 20bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.31% in 2022, then tumbled by -69bps to 0.52% in 2023, then soared by 38bps to 0.32% in 2024.
  • Business Quant data shows Return on Capital Employed for AUTL at 0.32% in Q4 2024, 0.28% in Q3 2024, and 0.52% in Q4 2023.